Linagliptin and Metformin Extended-Release Tablets and Oprelvekin Subcutaneous
Determining the interaction of Linagliptin and Metformin Extended-Release Tablets and Oprelvekin Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: linagliptin / metformin
Brand name: Jentadueto, Jentadueto XR
Synonyms: Linagliptin and metformin, Linagliptin and Metformin
Generic Name: oprelvekin
Brand name:
Synonyms: Oprelvekin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Linagliptin and Metformin Extended-Release Tablets-Opsumit
- Linagliptin and Metformin Extended-Release Tablets-Opti-Clear
- Linagliptin and Metformin Extended-Release Tablets-OptiFlex Complete
- Linagliptin and Metformin Extended-Release Tablets-OptiFlex-C
- Linagliptin and Metformin Extended-Release Tablets-Optiflex-G
- Linagliptin and Metformin Extended-Release Tablets-Optigene 3
- Oprelvekin Subcutaneous-Linagliptin and Metformin Tablets
- Oprelvekin Subcutaneous-Lincocin
- Oprelvekin Subcutaneous-Lincomycin
- Oprelvekin Subcutaneous-Lincomycin Hydrochloride
- Oprelvekin Subcutaneous-Lincomycin Injection
- Oprelvekin Subcutaneous-Lincomycin Oral, Injection